

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 5.66576516 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.52565949 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.40822556 |
| 4 | regulation of fibrinolysis (GO:0051917) | 5.34108175 |
| 5 | complement activation, alternative pathway (GO:0006957) | 5.33569869 |
| 6 | vocalization behavior (GO:0071625) | 5.30987622 |
| 7 | regulation of protein activation cascade (GO:2000257) | 5.30963509 |
| 8 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.20936364 |
| 9 | L-phenylalanine catabolic process (GO:0006559) | 5.20936364 |
| 10 | negative regulation of fibrinolysis (GO:0051918) | 5.19266808 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 5.17879792 |
| 12 | glutamate receptor signaling pathway (GO:0007215) | 5.13926278 |
| 13 | regulation of complement activation (GO:0030449) | 5.13171310 |
| 14 | locomotory exploration behavior (GO:0035641) | 5.07320155 |
| 15 | protein carboxylation (GO:0018214) | 5.07016247 |
| 16 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.07016247 |
| 17 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.84388824 |
| 18 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.81883324 |
| 19 | protein localization to synapse (GO:0035418) | 4.74814589 |
| 20 | glutamate secretion (GO:0014047) | 4.70456612 |
| 21 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.70122336 |
| 22 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.66363783 |
| 23 | L-phenylalanine metabolic process (GO:0006558) | 4.66363783 |
| 24 | synaptic vesicle exocytosis (GO:0016079) | 4.62814740 |
| 25 | neuronal action potential propagation (GO:0019227) | 4.61636977 |
| 26 | synaptic vesicle maturation (GO:0016188) | 4.59889115 |
| 27 | synaptic transmission, glutamatergic (GO:0035249) | 4.57884053 |
| 28 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.54911090 |
| 29 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.49124120 |
| 30 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.49118812 |
| 31 | positive regulation of synapse maturation (GO:0090129) | 4.31000085 |
| 32 | exogenous drug catabolic process (GO:0042738) | 4.25245231 |
| 33 | exploration behavior (GO:0035640) | 4.24787850 |
| 34 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.24496811 |
| 35 | epoxygenase P450 pathway (GO:0019373) | 4.23272927 |
| 36 | regulation of plasminogen activation (GO:0010755) | 4.20327436 |
| 37 | drug catabolic process (GO:0042737) | 4.08843073 |
| 38 | neuron-neuron synaptic transmission (GO:0007270) | 4.05288011 |
| 39 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.99198884 |
| 40 | blood coagulation, intrinsic pathway (GO:0007597) | 3.99068602 |
| 41 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.98672891 |
| 42 | long-term memory (GO:0007616) | 3.95297876 |
| 43 | plasma lipoprotein particle remodeling (GO:0034369) | 3.94801662 |
| 44 | protein-lipid complex remodeling (GO:0034368) | 3.94801662 |
| 45 | macromolecular complex remodeling (GO:0034367) | 3.94801662 |
| 46 | neuron recognition (GO:0008038) | 3.94044933 |
| 47 | neuron cell-cell adhesion (GO:0007158) | 3.93777163 |
| 48 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.93192578 |
| 49 | dendritic spine morphogenesis (GO:0060997) | 3.92329486 |
| 50 | omega-hydroxylase P450 pathway (GO:0097267) | 3.90107222 |
| 51 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.89436897 |
| 52 | negative regulation of sterol transport (GO:0032372) | 3.88706623 |
| 53 | negative regulation of cholesterol transport (GO:0032375) | 3.88706623 |
| 54 | glutamate metabolic process (GO:0006536) | 3.85997421 |
| 55 | glyoxylate metabolic process (GO:0046487) | 3.84440016 |
| 56 | axonal fasciculation (GO:0007413) | 3.83873928 |
| 57 | regulation of synaptic vesicle transport (GO:1902803) | 3.81321312 |
| 58 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.80771073 |
| 59 | regulation of postsynaptic membrane potential (GO:0060078) | 3.75460791 |
| 60 | regulation of synaptic plasticity (GO:0048167) | 3.75317543 |
| 61 | neurotransmitter secretion (GO:0007269) | 3.75246885 |
| 62 | high-density lipoprotein particle remodeling (GO:0034375) | 3.67759187 |
| 63 | cholesterol efflux (GO:0033344) | 3.67271365 |
| 64 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.65071083 |
| 65 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.63527992 |
| 66 | ethanol oxidation (GO:0006069) | 3.60059872 |
| 67 | dendritic spine organization (GO:0097061) | 3.58361788 |
| 68 | reverse cholesterol transport (GO:0043691) | 3.57301789 |
| 69 | synaptic vesicle endocytosis (GO:0048488) | 3.52270414 |
| 70 | positive regulation of membrane potential (GO:0045838) | 3.50916855 |
| 71 | regulation of cholesterol esterification (GO:0010872) | 3.49746832 |
| 72 | fibrinolysis (GO:0042730) | 3.49389420 |
| 73 | cellular potassium ion homeostasis (GO:0030007) | 3.48067130 |
| 74 | long-term synaptic potentiation (GO:0060291) | 3.47492344 |
| 75 | positive regulation of dendritic spine development (GO:0060999) | 3.46939228 |
| 76 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.45135272 |
| 77 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.45135272 |
| 78 | aromatic amino acid family catabolic process (GO:0009074) | 3.45022734 |
| 79 | layer formation in cerebral cortex (GO:0021819) | 3.43607599 |
| 80 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.43198567 |
| 81 | regulation of synapse structural plasticity (GO:0051823) | 3.42546275 |
| 82 | protein activation cascade (GO:0072376) | 3.41822979 |
| 83 | intestinal cholesterol absorption (GO:0030299) | 3.39470011 |
| 84 | regulation of apoptotic cell clearance (GO:2000425) | 3.38133304 |
| 85 | gamma-aminobutyric acid transport (GO:0015812) | 3.34772389 |
| 86 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.33891750 |
| 87 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.33123189 |
| 88 | regulation of vesicle fusion (GO:0031338) | 3.32859364 |
| 89 | innervation (GO:0060384) | 3.31874610 |
| 90 | imidazole-containing compound metabolic process (GO:0052803) | 3.29672789 |
| 91 | regulation of dendritic spine development (GO:0060998) | 3.29163882 |
| 92 | proline transport (GO:0015824) | 3.28880549 |
| 93 | behavioral defense response (GO:0002209) | 3.28572149 |
| 94 | behavioral fear response (GO:0001662) | 3.28572149 |
| 95 | transmission of nerve impulse (GO:0019226) | 3.27966698 |
| 96 | cell communication by electrical coupling (GO:0010644) | 3.25596833 |
| 97 | acute-phase response (GO:0006953) | 3.25533300 |
| 98 | complement activation, classical pathway (GO:0006958) | 3.24884929 |
| 99 | positive regulation of fibroblast migration (GO:0010763) | 3.24160083 |
| 100 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.21375690 |
| 101 | triglyceride homeostasis (GO:0070328) | 3.20082471 |
| 102 | acylglycerol homeostasis (GO:0055090) | 3.20082471 |
| 103 | regulation of synapse maturation (GO:0090128) | 3.19614475 |
| 104 | axon ensheathment in central nervous system (GO:0032291) | 3.18596504 |
| 105 | central nervous system myelination (GO:0022010) | 3.18596504 |
| 106 | chemosensory behavior (GO:0007635) | 3.17650579 |
| 107 | presynaptic membrane assembly (GO:0097105) | 3.16506626 |
| 108 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.16268377 |
| 109 | cellular sodium ion homeostasis (GO:0006883) | 3.13126285 |
| 110 | C4-dicarboxylate transport (GO:0015740) | 3.13013418 |
| 111 | presynaptic membrane organization (GO:0097090) | 3.12982132 |
| 112 | membrane depolarization (GO:0051899) | 3.12662255 |
| 113 | postsynaptic membrane organization (GO:0001941) | 3.11464650 |
| 114 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.11192691 |
| 115 | complement activation (GO:0006956) | 3.10925595 |
| 116 | cerebellar granule cell differentiation (GO:0021707) | 3.10761135 |
| 117 | gonadal mesoderm development (GO:0007506) | 3.10202241 |
| 118 | fear response (GO:0042596) | 3.09617891 |
| 119 | serine family amino acid catabolic process (GO:0009071) | 3.09175389 |
| 120 | regulation of triglyceride catabolic process (GO:0010896) | 3.08971471 |
| 121 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.08816422 |
| 122 | low-density lipoprotein particle remodeling (GO:0034374) | 3.08699155 |
| 123 | negative regulation of protein activation cascade (GO:2000258) | 3.08515148 |
| 124 | plasma lipoprotein particle organization (GO:0071827) | 3.08447199 |
| 125 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.06061402 |
| 126 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.03762940 |
| 127 | long term synaptic depression (GO:0060292) | 3.01472943 |
| 128 | learning (GO:0007612) | 2.99669352 |
| 129 | protein-lipid complex subunit organization (GO:0071825) | 2.98665735 |
| 130 | central nervous system projection neuron axonogenesis (GO:0021952) | 2.97362827 |
| 131 | neurotransmitter transport (GO:0006836) | 2.97049373 |
| 132 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.96954301 |
| 133 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.95190247 |
| 134 | negative regulation of lipase activity (GO:0060192) | 2.94256156 |
| 135 | phospholipid efflux (GO:0033700) | 2.94218479 |
| 136 | plasma lipoprotein particle assembly (GO:0034377) | 2.93866352 |
| 137 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.93804769 |
| 138 | opsonization (GO:0008228) | 2.93691378 |
| 139 | neuromuscular process controlling balance (GO:0050885) | 2.93376780 |
| 140 | response to histamine (GO:0034776) | 2.91633978 |
| 141 | regulation of humoral immune response (GO:0002920) | 2.91454724 |
| 142 | regulation of synaptic transmission (GO:0050804) | 2.91211330 |
| 143 | regulation of glutamate secretion (GO:0014048) | 2.91002921 |
| 144 | dendrite morphogenesis (GO:0048813) | 2.90774264 |
| 145 | membrane depolarization during action potential (GO:0086010) | 2.89779902 |
| 146 | establishment of nucleus localization (GO:0040023) | 2.89313783 |
| 147 | urea metabolic process (GO:0019627) | 2.89178237 |
| 148 | positive regulation of vesicle fusion (GO:0031340) | 2.88897551 |
| 149 | negative regulation of blood coagulation (GO:0030195) | 2.88600498 |
| 150 | negative regulation of hemostasis (GO:1900047) | 2.88600498 |
| 151 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.87550940 |
| 152 | negative regulation of amino acid transport (GO:0051956) | 2.87337214 |
| 153 | regulation of neurotransmitter secretion (GO:0046928) | 2.85802204 |
| 154 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.85472877 |
| 155 | ethanol metabolic process (GO:0006067) | 2.84786102 |
| 156 | neuromuscular process controlling posture (GO:0050884) | 2.84332321 |
| 157 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.82671427 |
| 158 | regulation of neurotransmitter levels (GO:0001505) | 2.81553308 |
| 159 | activation of protein kinase A activity (GO:0034199) | 2.81355575 |
| 160 | positive regulation of synaptic transmission (GO:0050806) | 2.80914493 |
| 161 | sodium ion export (GO:0071436) | 2.80653640 |
| 162 | cell migration in hindbrain (GO:0021535) | 2.80517263 |
| 163 | positive regulation of dendrite development (GO:1900006) | 2.79569062 |
| 164 | plasma lipoprotein particle clearance (GO:0034381) | 2.78585281 |
| 165 | ephrin receptor signaling pathway (GO:0048013) | 2.77877888 |
| 166 | protein-lipid complex assembly (GO:0065005) | 2.77553763 |
| 167 | drug metabolic process (GO:0017144) | 2.77520286 |
| 168 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 2.76618461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 6.14210627 |
| 2 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.65890424 |
| 3 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.63526567 |
| 4 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.12749268 |
| 5 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.10974626 |
| 6 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 3.05520378 |
| 7 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.80684111 |
| 8 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.80684111 |
| 9 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.79369642 |
| 10 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.75264697 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.71857291 |
| 12 | * SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.67338079 |
| 13 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.54947417 |
| 14 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51894420 |
| 15 | * EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.51572006 |
| 16 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.50009146 |
| 17 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.48298591 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.46579577 |
| 19 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.45931025 |
| 20 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.45799592 |
| 21 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.26786546 |
| 22 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.24378267 |
| 23 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.23692705 |
| 24 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.21057578 |
| 25 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.18251528 |
| 26 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.15606050 |
| 27 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.12086035 |
| 28 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.11133706 |
| 29 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.92514910 |
| 30 | * REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.92085788 |
| 31 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.88529741 |
| 32 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.86946741 |
| 33 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.81467451 |
| 34 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.73378415 |
| 35 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.72554696 |
| 36 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.72392127 |
| 37 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.71688412 |
| 38 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.68669199 |
| 39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.64128910 |
| 40 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60501547 |
| 41 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.60024954 |
| 42 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.59992726 |
| 43 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.58945006 |
| 44 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.57918742 |
| 45 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.54800881 |
| 46 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.51457264 |
| 47 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.50444090 |
| 48 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.49397926 |
| 49 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.49245814 |
| 50 | * PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.49187976 |
| 51 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.44427145 |
| 52 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.43569134 |
| 53 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.42357031 |
| 54 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.37308789 |
| 55 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.37189921 |
| 56 | P300_19829295_ChIP-Seq_ESCs_Human | 1.32988352 |
| 57 | TP53_16413492_ChIP-PET_HCT116_Human | 1.30810797 |
| 58 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29833873 |
| 59 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.27785442 |
| 60 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.26220275 |
| 61 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.25366156 |
| 62 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.25190670 |
| 63 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.25062323 |
| 64 | AR_25329375_ChIP-Seq_VCAP_Human | 1.23019973 |
| 65 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23018026 |
| 66 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.22453633 |
| 67 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.22417420 |
| 68 | AR_19668381_ChIP-Seq_PC3_Human | 1.21381705 |
| 69 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.21370078 |
| 70 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.19654578 |
| 71 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.18339737 |
| 72 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.17959753 |
| 73 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.16073478 |
| 74 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.15589563 |
| 75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.15077504 |
| 76 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.14923434 |
| 77 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.12886465 |
| 78 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.12562224 |
| 79 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.11268701 |
| 80 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.10869183 |
| 81 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.10859161 |
| 82 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.10680580 |
| 83 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09814464 |
| 84 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.09568669 |
| 85 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.09520628 |
| 86 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.09170493 |
| 87 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08952133 |
| 88 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.08700820 |
| 89 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.08078192 |
| 90 | P68_20966046_ChIP-Seq_HELA_Human | 1.06155837 |
| 91 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.06120954 |
| 92 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.05669542 |
| 93 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.05496462 |
| 94 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.04723207 |
| 95 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.04149364 |
| 96 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 1.03828800 |
| 97 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.02976610 |
| 98 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02594840 |
| 99 | VDR_22108803_ChIP-Seq_LS180_Human | 1.01923025 |
| 100 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01165325 |
| 101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.00108322 |
| 102 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.99954565 |
| 103 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.99464635 |
| 104 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 0.99100004 |
| 105 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.98606425 |
| 106 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.97805088 |
| 107 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.97606330 |
| 108 | OCT4_19829295_ChIP-Seq_ESCs_Human | 0.97358301 |
| 109 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.97146400 |
| 110 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96726036 |
| 111 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.96487336 |
| 112 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.96417488 |
| 113 | FUS_26573619_Chip-Seq_HEK293_Human | 0.96415702 |
| 114 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.96278595 |
| 115 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.95920549 |
| 116 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94876647 |
| 117 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.94635224 |
| 118 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93643178 |
| 119 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.93260140 |
| 120 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.93160335 |
| 121 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 0.92868858 |
| 122 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.92232112 |
| 123 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.92199430 |
| 124 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.90764735 |
| 125 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.89979306 |
| 126 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.89623071 |
| 127 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.89535837 |
| 128 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.89413859 |
| 129 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89264954 |
| 130 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89264954 |
| 131 | * PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.88787709 |
| 132 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.88623513 |
| 133 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.88396797 |
| 134 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.88390574 |
| 135 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.87899235 |
| 136 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.87874389 |
| 137 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.87697494 |
| 138 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 0.87192656 |
| 139 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.85313927 |
| 140 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.85302394 |
| 141 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.83626450 |
| 142 | * NEUROD2_26341353_ChIP-Seq_CORTEX_Mouse | 0.80478338 |
| 143 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.79825859 |
| 144 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.77547106 |
| 145 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.75644736 |
| 146 | SA1_27219007_Chip-Seq_Bcells_Human | 0.75496124 |
| 147 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.74799104 |
| 148 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.73249778 |
| 149 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.72964247 |
| 150 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 0.72383640 |
| 151 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.72236923 |
| 152 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 0.71280604 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 7.33505376 |
| 2 | MP0003880_abnormal_central_pattern | 5.28191643 |
| 3 | MP0002139_abnormal_hepatobiliary_system | 4.52232229 |
| 4 | * MP0003635_abnormal_synaptic_transmissio | 4.22633677 |
| 5 | MP0005360_urolithiasis | 4.16925939 |
| 6 | MP0004270_analgesia | 3.45986792 |
| 7 | * MP0002063_abnormal_learning/memory/cond | 3.35960135 |
| 8 | MP0009745_abnormal_behavioral_response | 3.33292705 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 3.27339598 |
| 10 | MP0003195_calcinosis | 3.16083119 |
| 11 | MP0005365_abnormal_bile_salt | 3.05784588 |
| 12 | MP0002064_seizures | 2.99972609 |
| 13 | MP0001968_abnormal_touch/_nociception | 2.84506911 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.77427306 |
| 15 | MP0005085_abnormal_gallbladder_physiolo | 2.73876736 |
| 16 | * MP0002572_abnormal_emotion/affect_behav | 2.68790195 |
| 17 | MP0002736_abnormal_nociception_after | 2.59802196 |
| 18 | MP0009046_muscle_twitch | 2.53117481 |
| 19 | MP0002272_abnormal_nervous_system | 2.46080550 |
| 20 | MP0010329_abnormal_lipoprotein_level | 2.39839249 |
| 21 | MP0009780_abnormal_chondrocyte_physiolo | 2.37475969 |
| 22 | MP0002735_abnormal_chemical_nociception | 2.26759519 |
| 23 | MP0001440_abnormal_grooming_behavior | 2.26164084 |
| 24 | MP0001486_abnormal_startle_reflex | 2.21400210 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 2.11724657 |
| 26 | MP0003252_abnormal_bile_duct | 2.08040962 |
| 27 | MP0003329_amyloid_beta_deposits | 2.03226521 |
| 28 | MP0005670_abnormal_white_adipose | 1.87784960 |
| 29 | MP0001666_abnormal_nutrient_absorption | 1.86764483 |
| 30 | MP0002067_abnormal_sensory_capabilities | 1.77781154 |
| 31 | MP0005423_abnormal_somatic_nervous | 1.76771868 |
| 32 | MP0002837_dystrophic_cardiac_calcinosis | 1.76703328 |
| 33 | MP0000778_abnormal_nervous_system | 1.76208229 |
| 34 | MP0002184_abnormal_innervation | 1.75048951 |
| 35 | MP0004858_abnormal_nervous_system | 1.74887539 |
| 36 | MP0003879_abnormal_hair_cell | 1.70393847 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.66180111 |
| 38 | MP0010368_abnormal_lymphatic_system | 1.61110286 |
| 39 | MP0008569_lethality_at_weaning | 1.58846814 |
| 40 | MP0000566_synostosis | 1.58683668 |
| 41 | MP0002557_abnormal_social/conspecific_i | 1.55661599 |
| 42 | MP0000751_myopathy | 1.55107392 |
| 43 | MP0001970_abnormal_pain_threshold | 1.53015153 |
| 44 | MP0004145_abnormal_muscle_electrophysio | 1.52785673 |
| 45 | MP0006276_abnormal_autonomic_nervous | 1.50852099 |
| 46 | MP0003283_abnormal_digestive_organ | 1.49827740 |
| 47 | MP0005409_darkened_coat_color | 1.47888123 |
| 48 | MP0000955_abnormal_spinal_cord | 1.45227805 |
| 49 | MP0002822_catalepsy | 1.44943711 |
| 50 | MP0004811_abnormal_neuron_physiology | 1.44751998 |
| 51 | MP0004885_abnormal_endolymph | 1.43253072 |
| 52 | MP0002909_abnormal_adrenal_gland | 1.37354161 |
| 53 | MP0001502_abnormal_circadian_rhythm | 1.36803984 |
| 54 | MP0003172_abnormal_lysosome_physiology | 1.36022849 |
| 55 | MP0005646_abnormal_pituitary_gland | 1.35832094 |
| 56 | MP0005332_abnormal_amino_acid | 1.32308493 |
| 57 | MP0000920_abnormal_myelination | 1.29279823 |
| 58 | * MP0002066_abnormal_motor_capabilities/c | 1.28739525 |
| 59 | MP0003122_maternal_imprinting | 1.27434279 |
| 60 | MP0003868_abnormal_feces_composition | 1.27255998 |
| 61 | MP0004924_abnormal_behavior | 1.24348223 |
| 62 | MP0005386_behavior/neurological_phenoty | 1.24348223 |
| 63 | MP0002118_abnormal_lipid_homeostasis | 1.24252664 |
| 64 | MP0002882_abnormal_neuron_morphology | 1.23850930 |
| 65 | MP0003633_abnormal_nervous_system | 1.19523642 |
| 66 | MP0003123_paternal_imprinting | 1.16397031 |
| 67 | MP0010386_abnormal_urinary_bladder | 1.15668136 |
| 68 | MP0003787_abnormal_imprinting | 1.14424998 |
| 69 | MP0003075_altered_response_to | 1.11183152 |
| 70 | MP0001984_abnormal_olfaction | 1.06984845 |
| 71 | MP0001986_abnormal_taste_sensitivity | 1.06605717 |
| 72 | MP0005645_abnormal_hypothalamus_physiol | 1.05910388 |
| 73 | MP0002089_abnormal_postnatal_growth/wei | 1.05531798 |
| 74 | MP0003631_nervous_system_phenotype | 1.04757987 |
| 75 | MP0004510_myositis | 1.04203375 |
| 76 | MP0000604_amyloidosis | 0.99527155 |
| 77 | * MP0002152_abnormal_brain_morphology | 0.98910692 |
| 78 | MP0002138_abnormal_hepatobiliary_system | 0.96821860 |
| 79 | MP0004484_altered_response_of | 0.96637231 |
| 80 | MP0005535_abnormal_body_temperature | 0.96290033 |
| 81 | MP0002069_abnormal_eating/drinking_beha | 0.94514647 |
| 82 | MP0001177_atelectasis | 0.91441003 |
| 83 | MP0009840_abnormal_foam_cell | 0.90433161 |
| 84 | MP0002876_abnormal_thyroid_physiology | 0.88460113 |
| 85 | MP0001188_hyperpigmentation | 0.87342167 |
| 86 | MP0003191_abnormal_cellular_cholesterol | 0.87008205 |
| 87 | MP0004215_abnormal_myocardial_fiber | 0.85898453 |
| 88 | MP0005623_abnormal_meninges_morphology | 0.85600660 |
| 89 | MP0001348_abnormal_lacrimal_gland | 0.84936633 |
| 90 | MP0000013_abnormal_adipose_tissue | 0.84847578 |
| 91 | * MP0002249_abnormal_larynx_morphology | 0.83907180 |
| 92 | MP0004142_abnormal_muscle_tone | 0.83499493 |
| 93 | MP0000639_abnormal_adrenal_gland | 0.80906321 |
| 94 | MP0008874_decreased_physiological_sensi | 0.80669106 |
| 95 | MP0001765_abnormal_ion_homeostasis | 0.80370610 |
| 96 | MP0003632_abnormal_nervous_system | 0.79073669 |
| 97 | MP0004085_abnormal_heartbeat | 0.75946834 |
| 98 | MP0000609_abnormal_liver_physiology | 0.75768639 |
| 99 | MP0008872_abnormal_physiological_respon | 0.74718992 |
| 100 | MP0002971_abnormal_brown_adipose | 0.74586883 |
| 101 | MP0001963_abnormal_hearing_physiology | 0.74528288 |
| 102 | MP0005187_abnormal_penis_morphology | 0.74188307 |
| 103 | MP0003634_abnormal_glial_cell | 0.73413860 |
| 104 | MP0008961_abnormal_basal_metabolism | 0.73367441 |
| 105 | MP0004043_abnormal_pH_regulation | 0.72305872 |
| 106 | MP0010234_abnormal_vibrissa_follicle | 0.72106131 |
| 107 | MP0001905_abnormal_dopamine_level | 0.71985757 |
| 108 | MP0004742_abnormal_vestibular_system | 0.71503119 |
| 109 | MP0005448_abnormal_energy_balance | 0.71348517 |
| 110 | MP0005167_abnormal_blood-brain_barrier | 0.69917030 |
| 111 | MP0004233_abnormal_muscle_weight | 0.66611275 |
| 112 | MP0001664_abnormal_digestion | 0.65294804 |
| 113 | MP0000003_abnormal_adipose_tissue | 0.65143664 |
| 114 | MP0002078_abnormal_glucose_homeostasis | 0.62290063 |
| 115 | MP0003136_yellow_coat_color | 0.60885727 |
| 116 | * MP0005595_abnormal_vascular_smooth | 0.60456102 |
| 117 | MP0001485_abnormal_pinna_reflex | 0.59020995 |
| 118 | MP0003690_abnormal_glial_cell | 0.58697481 |
| 119 | MP0002229_neurodegeneration | 0.58399069 |
| 120 | MP0005499_abnormal_olfactory_system | 0.58099314 |
| 121 | MP0005394_taste/olfaction_phenotype | 0.58099314 |
| 122 | MP0000747_muscle_weakness | 0.56552690 |
| 123 | MP0005551_abnormal_eye_electrophysiolog | 0.55475949 |
| 124 | MP0004130_abnormal_muscle_cell | 0.54841414 |
| 125 | * MP0002752_abnormal_somatic_nervous | 0.54717902 |
| 126 | MP0005620_abnormal_muscle_contractility | 0.54178543 |
| 127 | MP0005166_decreased_susceptibility_to | 0.50862005 |
| 128 | MP0005171_absent_coat_pigmentation | 0.50172692 |
| 129 | MP0003045_fibrosis | 0.50120235 |
| 130 | * MP0000026_abnormal_inner_ear | 0.49634525 |
| 131 | * MP0003861_abnormal_nervous_system | 0.47193587 |
| 132 | MP0010769_abnormal_survival | 0.46697133 |
| 133 | MP0000631_abnormal_neuroendocrine_gland | 0.46357879 |
| 134 | MP0000759_abnormal_skeletal_muscle | 0.45690010 |
| 135 | MP0002638_abnormal_pupillary_reflex | 0.45289930 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 8.50130421 |
| 2 | Deep venous thrombosis (HP:0002625) | 7.89745645 |
| 3 | Complement deficiency (HP:0004431) | 7.10297447 |
| 4 | Prolonged partial thromboplastin time (HP:0003645) | 6.35040446 |
| 5 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.95258847 |
| 6 | Focal seizures (HP:0007359) | 5.90687121 |
| 7 | Myokymia (HP:0002411) | 5.78713378 |
| 8 | Joint hemorrhage (HP:0005261) | 5.48793464 |
| 9 | Abnormality of complement system (HP:0005339) | 5.33701794 |
| 10 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.00525160 |
| 11 | Atonic seizures (HP:0010819) | 4.97668937 |
| 12 | Visual hallucinations (HP:0002367) | 4.87799590 |
| 13 | Hypobetalipoproteinemia (HP:0003563) | 4.83026147 |
| 14 | Febrile seizures (HP:0002373) | 4.60533168 |
| 15 | Epileptic encephalopathy (HP:0200134) | 4.55750160 |
| 16 | Systemic lupus erythematosus (HP:0002725) | 4.46405321 |
| 17 | Absence seizures (HP:0002121) | 4.32521637 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 4.11365867 |
| 19 | Dialeptic seizures (HP:0011146) | 4.10883932 |
| 20 | Abnormality of the lower motor neuron (HP:0002366) | 4.08186668 |
| 21 | Hyperventilation (HP:0002883) | 4.03703403 |
| 22 | Glomerulonephritis (HP:0000099) | 4.02021034 |
| 23 | Hyperlipoproteinemia (HP:0010980) | 4.01510465 |
| 24 | Generalized tonic-clonic seizures (HP:0002069) | 3.86186596 |
| 25 | Xanthomatosis (HP:0000991) | 3.85595009 |
| 26 | Action tremor (HP:0002345) | 3.65043248 |
| 27 | Broad-based gait (HP:0002136) | 3.29816428 |
| 28 | Amblyopia (HP:0000646) | 3.25518431 |
| 29 | Conjugated hyperbilirubinemia (HP:0002908) | 3.22847359 |
| 30 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.18097554 |
| 31 | Cerebral inclusion bodies (HP:0100314) | 3.14214569 |
| 32 | Dysdiadochokinesis (HP:0002075) | 3.13976514 |
| 33 | Gaze-evoked nystagmus (HP:0000640) | 3.08727759 |
| 34 | Supranuclear gaze palsy (HP:0000605) | 3.06465042 |
| 35 | Poor eye contact (HP:0000817) | 3.03181257 |
| 36 | Dysmetria (HP:0001310) | 3.03102947 |
| 37 | Hypercholesterolemia (HP:0003124) | 2.95244642 |
| 38 | Abnormality of the common coagulation pathway (HP:0010990) | 2.94014843 |
| 39 | Hypolipoproteinemia (HP:0010981) | 2.92764618 |
| 40 | Hemorrhage of the eye (HP:0011885) | 2.90708673 |
| 41 | Hemiparesis (HP:0001269) | 2.88954354 |
| 42 | Impaired social interactions (HP:0000735) | 2.88026801 |
| 43 | Abnormal social behavior (HP:0012433) | 2.88026801 |
| 44 | Drooling (HP:0002307) | 2.83035263 |
| 45 | Excessive salivation (HP:0003781) | 2.83035263 |
| 46 | Status epilepticus (HP:0002133) | 2.82238482 |
| 47 | Truncal ataxia (HP:0002078) | 2.78502954 |
| 48 | Depression (HP:0000716) | 2.77786653 |
| 49 | Mitral stenosis (HP:0001718) | 2.76065698 |
| 50 | Anxiety (HP:0000739) | 2.64868113 |
| 51 | Hypoalphalipoproteinemia (HP:0003233) | 2.61847445 |
| 52 | Impaired smooth pursuit (HP:0007772) | 2.57784591 |
| 53 | Hemiplegia (HP:0002301) | 2.56429189 |
| 54 | Neurofibrillary tangles (HP:0002185) | 2.56380819 |
| 55 | Scanning speech (HP:0002168) | 2.55067910 |
| 56 | Abnormal eating behavior (HP:0100738) | 2.52473100 |
| 57 | Absent speech (HP:0001344) | 2.50642099 |
| 58 | Epileptiform EEG discharges (HP:0011182) | 2.49307086 |
| 59 | Genetic anticipation (HP:0003743) | 2.46560694 |
| 60 | Nephritis (HP:0000123) | 2.46238549 |
| 61 | Lymphangioma (HP:0100764) | 2.44302091 |
| 62 | Bronchomalacia (HP:0002780) | 2.39795495 |
| 63 | Diplopia (HP:0000651) | 2.37857478 |
| 64 | Abnormality of binocular vision (HP:0011514) | 2.37857478 |
| 65 | Postural instability (HP:0002172) | 2.37725049 |
| 66 | Dysmetric saccades (HP:0000641) | 2.35309309 |
| 67 | Akinesia (HP:0002304) | 2.33828521 |
| 68 | Abnormality of the intrinsic pathway (HP:0010989) | 2.32985238 |
| 69 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.31043880 |
| 70 | Delayed CNS myelination (HP:0002188) | 2.28809300 |
| 71 | Ankle clonus (HP:0011448) | 2.26252499 |
| 72 | Focal dystonia (HP:0004373) | 2.24783727 |
| 73 | Torticollis (HP:0000473) | 2.24314629 |
| 74 | Fetal akinesia sequence (HP:0001989) | 2.20610714 |
| 75 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.20588381 |
| 76 | Stereotypic behavior (HP:0000733) | 2.18493575 |
| 77 | EEG with generalized epileptiform discharges (HP:0011198) | 2.18405504 |
| 78 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 2.18159211 |
| 79 | Global brain atrophy (HP:0002283) | 2.17176027 |
| 80 | Intrahepatic cholestasis (HP:0001406) | 2.12270100 |
| 81 | Skin nodule (HP:0200036) | 2.11998193 |
| 82 | Annular pancreas (HP:0001734) | 2.11836826 |
| 83 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.11824909 |
| 84 | Epidermoid cyst (HP:0200040) | 2.11619702 |
| 85 | Heart block (HP:0012722) | 2.11346914 |
| 86 | Impaired vibratory sensation (HP:0002495) | 2.08857860 |
| 87 | Menorrhagia (HP:0000132) | 2.08312021 |
| 88 | Cerebral aneurysm (HP:0004944) | 2.07640516 |
| 89 | Bradykinesia (HP:0002067) | 2.05091657 |
| 90 | Hypoventilation (HP:0002791) | 2.04217589 |
| 91 | Spontaneous abortion (HP:0005268) | 2.03725260 |
| 92 | Hydroureter (HP:0000072) | 2.03483992 |
| 93 | Lower limb asymmetry (HP:0100559) | 2.02377139 |
| 94 | Intention tremor (HP:0002080) | 2.01953753 |
| 95 | Hypsarrhythmia (HP:0002521) | 1.97345671 |
| 96 | Delusions (HP:0000746) | 1.96529310 |
| 97 | Protruding tongue (HP:0010808) | 1.96008119 |
| 98 | Atrioventricular block (HP:0001678) | 1.94897709 |
| 99 | Abnormal atrioventricular conduction (HP:0005150) | 1.92834402 |
| 100 | Lower limb amyotrophy (HP:0007210) | 1.91893145 |
| 101 | Incomplete penetrance (HP:0003829) | 1.90864132 |
| 102 | Urinary urgency (HP:0000012) | 1.89978709 |
| 103 | Pointed chin (HP:0000307) | 1.89721218 |
| 104 | Generalized myoclonic seizures (HP:0002123) | 1.88961947 |
| 105 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.88457539 |
| 106 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.88198309 |
| 107 | Craniofacial dystonia (HP:0012179) | 1.87520589 |
| 108 | J-shaped sella turcica (HP:0002680) | 1.87076244 |
| 109 | Sleep apnea (HP:0010535) | 1.86818399 |
| 110 | Rapidly progressive (HP:0003678) | 1.85895479 |
| 111 | Narrow nasal bridge (HP:0000446) | 1.85174290 |
| 112 | Purpura (HP:0000979) | 1.85136846 |
| 113 | Limb dystonia (HP:0002451) | 1.83737300 |
| 114 | Insomnia (HP:0100785) | 1.82103097 |
| 115 | Neonatal onset (HP:0003623) | 1.81843183 |
| 116 | Abnormality of salivation (HP:0100755) | 1.81432102 |
| 117 | Vascular calcification (HP:0004934) | 1.80734037 |
| 118 | Slender build (HP:0001533) | 1.80720860 |
| 119 | Retinal atrophy (HP:0001105) | 1.80356837 |
| 120 | Psychosis (HP:0000709) | 1.78810833 |
| 121 | Papilledema (HP:0001085) | 1.78054055 |
| 122 | Anosmia (HP:0000458) | 1.77458189 |
| 123 | Type II lissencephaly (HP:0007260) | 1.76045835 |
| 124 | Confusion (HP:0001289) | 1.75888174 |
| 125 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.73900404 |
| 126 | Abnormality of the periventricular white matter (HP:0002518) | 1.72962070 |
| 127 | Gait ataxia (HP:0002066) | 1.72774936 |
| 128 | Thickened helices (HP:0000391) | 1.72602101 |
| 129 | Bundle branch block (HP:0011710) | 1.72132538 |
| 130 | Spinal canal stenosis (HP:0003416) | 1.71915340 |
| 131 | Lower limb muscle weakness (HP:0007340) | 1.71486517 |
| 132 | Spastic gait (HP:0002064) | 1.71445918 |
| 133 | Abnormality of the Achilles tendon (HP:0005109) | 1.71095920 |
| 134 | Achilles tendon contracture (HP:0001771) | 1.70911880 |
| 135 | Alacrima (HP:0000522) | 1.70793975 |
| 136 | Clonus (HP:0002169) | 1.70112677 |
| 137 | Tetraplegia (HP:0002445) | 1.69623587 |
| 138 | Oligodactyly (hands) (HP:0001180) | 1.69445006 |
| 139 | Blue irides (HP:0000635) | 1.68577455 |
| 140 | Aplasia involving bones of the extremities (HP:0009825) | 1.68025952 |
| 141 | Aplasia involving bones of the upper limbs (HP:0009823) | 1.68025952 |
| 142 | Aplasia of the phalanges of the hand (HP:0009802) | 1.68025952 |
| 143 | Cerebral hypomyelination (HP:0006808) | 1.67911450 |
| 144 | Polyphagia (HP:0002591) | 1.67876308 |
| 145 | Syncope (HP:0001279) | 1.67829311 |
| 146 | Obstructive sleep apnea (HP:0002870) | 1.67281022 |
| 147 | Facial shape deformation (HP:0011334) | 1.67134861 |
| 148 | Potter facies (HP:0002009) | 1.67134861 |
| 149 | Ventricular fibrillation (HP:0001663) | 1.66856352 |
| 150 | Insidious onset (HP:0003587) | 1.66467212 |
| 151 | Termporal pattern (HP:0011008) | 1.66467212 |
| 152 | Hypoplastic nipples (HP:0002557) | 1.66000051 |
| 153 | Neoplasm of the heart (HP:0100544) | 1.65806324 |
| 154 | Arthropathy (HP:0003040) | 1.62949424 |
| 155 | Visceral angiomatosis (HP:0100761) | 1.57753103 |
| 156 | Fat malabsorption (HP:0002630) | 1.57030241 |
| 157 | Cardiovascular calcification (HP:0011915) | 1.56197439 |
| 158 | Abnormal gallbladder physiology (HP:0012438) | 1.55991262 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 5.82423165 |
| 2 | EPHA4 | 5.79401741 |
| 3 | MAP3K9 | 3.01993956 |
| 4 | RIPK4 | 2.77205920 |
| 5 | DAPK2 | 2.55670923 |
| 6 | FGFR4 | 2.48287171 |
| 7 | MAP3K4 | 2.41804378 |
| 8 | TNIK | 2.39345957 |
| 9 | MINK1 | 2.33216319 |
| 10 | WNK4 | 2.29920003 |
| 11 | PRKD3 | 2.10829897 |
| 12 | MAP2K7 | 2.07358278 |
| 13 | KSR1 | 2.03560431 |
| 14 | KSR2 | 1.99430970 |
| 15 | MAP2K4 | 1.93114215 |
| 16 | DAPK1 | 1.85522840 |
| 17 | PAK6 | 1.82411040 |
| 18 | PLK2 | 1.74633618 |
| 19 | PTK2B | 1.72019246 |
| 20 | SIK2 | 1.69056238 |
| 21 | MAP3K12 | 1.65870562 |
| 22 | FGFR2 | 1.60983852 |
| 23 | SIK1 | 1.60614569 |
| 24 | FGFR3 | 1.60289444 |
| 25 | STK38 | 1.59529675 |
| 26 | CASK | 1.58314832 |
| 27 | TRIB3 | 1.51074366 |
| 28 | PRPF4B | 1.49783305 |
| 29 | MAP3K13 | 1.43104389 |
| 30 | MARK1 | 1.42674193 |
| 31 | CAMKK1 | 1.42274392 |
| 32 | WNK1 | 1.38841003 |
| 33 | PRKCG | 1.35503283 |
| 34 | NTRK2 | 1.34569098 |
| 35 | ARAF | 1.32622944 |
| 36 | PNCK | 1.32020980 |
| 37 | CDK5 | 1.30842638 |
| 38 | BMPR2 | 1.26307201 |
| 39 | GRK5 | 1.23855268 |
| 40 | NTRK1 | 1.16686592 |
| 41 | MUSK | 1.14012604 |
| 42 | ICK | 1.13961217 |
| 43 | ERBB2 | 1.13873537 |
| 44 | MAP2K6 | 1.13668675 |
| 45 | CAMK2A | 1.13291790 |
| 46 | FES | 1.09325033 |
| 47 | CAMK2B | 1.09066977 |
| 48 | CAMK1 | 1.06462230 |
| 49 | RAF1 | 1.03812848 |
| 50 | NME1 | 1.02168649 |
| 51 | MAPK13 | 1.00261770 |
| 52 | FER | 0.94580523 |
| 53 | ERN1 | 0.94464991 |
| 54 | MAP3K2 | 0.93703847 |
| 55 | CDK19 | 0.92978455 |
| 56 | RIPK1 | 0.91001542 |
| 57 | DDR2 | 0.90846711 |
| 58 | TYRO3 | 0.89191614 |
| 59 | MAP3K7 | 0.88624439 |
| 60 | PIK3CA | 0.84090869 |
| 61 | MAP3K11 | 0.81270330 |
| 62 | PKN1 | 0.80988447 |
| 63 | LATS2 | 0.75350083 |
| 64 | SGK1 | 0.73688296 |
| 65 | SGK494 | 0.73439362 |
| 66 | SGK223 | 0.73439362 |
| 67 | PRKCH | 0.73243974 |
| 68 | FGR | 0.72160295 |
| 69 | PAK3 | 0.71854736 |
| 70 | MARK2 | 0.69491685 |
| 71 | PRKD2 | 0.69425134 |
| 72 | KDR | 0.68695427 |
| 73 | PINK1 | 0.68049618 |
| 74 | SGK2 | 0.68013996 |
| 75 | CDK18 | 0.67692868 |
| 76 | PRKAA1 | 0.66482353 |
| 77 | PRKAA2 | 0.65455558 |
| 78 | CDK15 | 0.65358776 |
| 79 | MAP3K6 | 0.65178695 |
| 80 | DMPK | 0.64538515 |
| 81 | MAP3K1 | 0.63741866 |
| 82 | PDPK1 | 0.63718328 |
| 83 | DYRK1A | 0.63289652 |
| 84 | STK11 | 0.63225853 |
| 85 | CAMKK2 | 0.60951118 |
| 86 | CAMK1G | 0.59710404 |
| 87 | FGFR1 | 0.58723101 |
| 88 | SGK3 | 0.58112127 |
| 89 | MAP2K1 | 0.57787018 |
| 90 | CDC42BPA | 0.57636788 |
| 91 | CDK11A | 0.56837113 |
| 92 | RPS6KA2 | 0.56530270 |
| 93 | CAMK2D | 0.56202404 |
| 94 | CDK14 | 0.56168144 |
| 95 | CAMK4 | 0.54977074 |
| 96 | UHMK1 | 0.54815246 |
| 97 | CAMK2G | 0.54733117 |
| 98 | DYRK1B | 0.53592312 |
| 99 | ROCK2 | 0.51518270 |
| 100 | PKN2 | 0.51355863 |
| 101 | PDK1 | 0.50922975 |
| 102 | MAPKAPK5 | 0.50784278 |
| 103 | PRKCZ | 0.50433547 |
| 104 | PDGFRA | 0.49313161 |
| 105 | RET | 0.48665181 |
| 106 | PRKCE | 0.47536209 |
| 107 | ROCK1 | 0.47393227 |
| 108 | AKT3 | 0.46503803 |
| 109 | PHKG1 | 0.44420770 |
| 110 | PHKG2 | 0.44420770 |
| 111 | EPHB2 | 0.43446926 |
| 112 | RPS6KA3 | 0.43267409 |
| 113 | PRKACG | 0.43066621 |
| 114 | TNK2 | 0.42025861 |
| 115 | EEF2K | 0.41834008 |
| 116 | SRC | 0.41579878 |
| 117 | NEK6 | 0.40001536 |
| 118 | MAPK8 | 0.39826650 |
| 119 | OXSR1 | 0.39823256 |
| 120 | SIK3 | 0.39700712 |
| 121 | BRSK1 | 0.39412834 |
| 122 | PRKD1 | 0.39179537 |
| 123 | PRKG1 | 0.38976856 |
| 124 | PRKACA | 0.38637943 |
| 125 | DAPK3 | 0.38512321 |
| 126 | CSNK1D | 0.38383859 |
| 127 | FYN | 0.38373073 |
| 128 | BRAF | 0.37742797 |
| 129 | PTK2 | 0.36680546 |
| 130 | MAPK12 | 0.35055582 |
| 131 | MAPK10 | 0.33575187 |
| 132 | TAOK2 | 0.33280568 |
| 133 | MOS | 0.31998906 |
| 134 | PRKCA | 0.31998005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 4.16460739 |
| 2 | Long-term potentiation_Homo sapiens_hsa04720 | 3.08993516 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.79907510 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.73227015 |
| 5 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.71523810 |
| 6 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.69121091 |
| 7 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.66515895 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 2.34228157 |
| 9 | Salivary secretion_Homo sapiens_hsa04970 | 2.29366134 |
| 10 | Morphine addiction_Homo sapiens_hsa05032 | 2.15278065 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.14509156 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.14078688 |
| 13 | Olfactory transduction_Homo sapiens_hsa04740 | 2.12187453 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.07989294 |
| 15 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.05276091 |
| 16 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.98548692 |
| 17 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.96948296 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.94461793 |
| 19 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.92146463 |
| 20 | Insulin secretion_Homo sapiens_hsa04911 | 1.89184435 |
| 21 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.87753579 |
| 22 | Retinol metabolism_Homo sapiens_hsa00830 | 1.81634999 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.80492967 |
| 24 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.79525246 |
| 25 | Long-term depression_Homo sapiens_hsa04730 | 1.79028973 |
| 26 | Taste transduction_Homo sapiens_hsa04742 | 1.78278927 |
| 27 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.77024503 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.73677933 |
| 29 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.70879168 |
| 30 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.70438004 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.65117414 |
| 32 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.58070371 |
| 33 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.53589668 |
| 34 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.48031245 |
| 35 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.47123703 |
| 36 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.44755355 |
| 37 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.43342497 |
| 38 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.42265083 |
| 39 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.41650265 |
| 40 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.39566714 |
| 41 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.36293917 |
| 42 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.35622037 |
| 43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.34087916 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.32850247 |
| 45 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.29605358 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.28007636 |
| 47 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.27126820 |
| 48 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.26300414 |
| 49 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.25053481 |
| 50 | ABC transporters_Homo sapiens_hsa02010 | 1.24792786 |
| 51 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.20937891 |
| 52 | Axon guidance_Homo sapiens_hsa04360 | 1.18085103 |
| 53 | Cocaine addiction_Homo sapiens_hsa05030 | 1.15737487 |
| 54 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.13878447 |
| 55 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.12645972 |
| 56 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.11880236 |
| 57 | Melanogenesis_Homo sapiens_hsa04916 | 1.11604560 |
| 58 | Glioma_Homo sapiens_hsa05214 | 1.10902127 |
| 59 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.10249498 |
| 60 | Gap junction_Homo sapiens_hsa04540 | 1.09452319 |
| 61 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.08373932 |
| 62 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.06746341 |
| 63 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.06488981 |
| 64 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.06017725 |
| 65 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.04472651 |
| 66 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.00387797 |
| 67 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.00088603 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.94449360 |
| 69 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.93503139 |
| 70 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93215977 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.90819867 |
| 72 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.90561998 |
| 73 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.89009264 |
| 74 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.88643672 |
| 75 | Bile secretion_Homo sapiens_hsa04976 | 0.86229169 |
| 76 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.85424957 |
| 77 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.84326332 |
| 78 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.84150173 |
| 79 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.83566859 |
| 80 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.83048741 |
| 81 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.80751927 |
| 82 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.77241478 |
| 83 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.76828034 |
| 84 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.76343948 |
| 85 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.73392249 |
| 86 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.72702945 |
| 87 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.70464963 |
| 88 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.67396071 |
| 89 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.67175280 |
| 90 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.66593932 |
| 91 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.66568414 |
| 92 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.66188843 |
| 93 | Prion diseases_Homo sapiens_hsa05020 | 0.63774240 |
| 94 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.63139501 |
| 95 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.62294634 |
| 96 | Peroxisome_Homo sapiens_hsa04146 | 0.60812274 |
| 97 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.59811632 |
| 98 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.58797228 |
| 99 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.58257940 |
| 100 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.58013068 |
| 101 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.57741499 |
| 102 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.57172206 |
| 103 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.56364787 |
| 104 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.56231307 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.54713963 |
| 106 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.54028469 |
| 107 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.53755051 |
| 108 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.53120079 |
| 109 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.51653488 |
| 110 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.50911980 |
| 111 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.49439041 |
| 112 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.48883442 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48793057 |
| 114 | Circadian rhythm_Homo sapiens_hsa04710 | 0.47580639 |
| 115 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.47477745 |
| 116 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.47433624 |
| 117 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.46082242 |
| 118 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43700842 |
| 119 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.42679700 |
| 120 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.41584958 |
| 121 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.41138314 |
| 122 | Other glycan degradation_Homo sapiens_hsa00511 | 0.40702998 |
| 123 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.39333480 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38409659 |
| 125 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.38245223 |
| 126 | Carbon metabolism_Homo sapiens_hsa01200 | 0.37727939 |
| 127 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.35480463 |
| 128 | Alzheimers disease_Homo sapiens_hsa05010 | 0.35375538 |
| 129 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.35101230 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.34702833 |
| 131 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.33547535 |
| 132 | Sulfur relay system_Homo sapiens_hsa04122 | 0.33224868 |
| 133 | Phototransduction_Homo sapiens_hsa04744 | 0.32904359 |
| 134 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.29949120 |
| 135 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.29458888 |
| 136 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.24040217 |
| 137 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.23193961 |
| 138 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.21205021 |
| 139 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.19202542 |
| 140 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.18353568 |
| 141 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.17810535 |
| 142 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.17567495 |
| 143 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.17130678 |
| 144 | Mineral absorption_Homo sapiens_hsa04978 | 0.16869319 |
| 145 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.16781855 |
| 146 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.16590725 |
| 147 | Endometrial cancer_Homo sapiens_hsa05213 | 0.15423203 |

